MetaCap

Cadre (CDRE) vs Materion (MTRN)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Materion (MTRN) has outperformed Cadre (CDRE) over the past year, gaining 55.3% versus a loss of 26.8%. Over five years, MTRN leads with a +108.4% price change compared with +51.0% for CDRE. Materion is the larger company by market cap ($3.81 billion vs $1.26 billion), about 3.0 times the size, while Cadre is growing revenue faster (+7.5% vs +6.0%).

On valuation, Cadre trades at a lower forward P/E (18.5x vs 20.7x for Materion). Cadre offers the higher dividend yield (1.34% vs 0.31%). Cadre converts more of its revenue into profit, with a net margin of 7.2% versus 4.2%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

CDRE-26.83%MTRN+55.33%
+182%+66%-50%
Nov 21, 20251 yearNov 20, 2026
CDRE+41.11%MTRN+97.29%
+251%+106%-38%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

CDRE versus MTRN key metrics
MetricCDREMTRN
Share price$29.45$182.47
Market cap$1.26B$3.81B
1-day change-3.63%-10.02%
YTD return-27.89%+46.77%
1-year return-26.83%+55.33%
5-year return+51.03%+108.37%
P/E ratio (TTM)32.3637.39
Forward P/E18.5320.72
EPS (TTM)$0.91$4.88
Dividend yield1.34%0.31%
Annual dividend$0.395$0.57
Revenue (latest FY)$610.31M$1.79B
Revenue growth (YoY)+7.53%+6.04%
Net income (latest FY)$44.14M$74.82M
Gross margin42.54%17.27%
Operating margin11.04%6.15%
Net margin7.23%4.19%
52-week high$48.76$324.99
52-week low$24.07$116.02
Distance from 52-week high-39.60%-43.85%
Analyst consensusstrong_buynone
Avg. price target upside+59.02%+44.96%
Average volume464.00K248.26K
Shares outstanding42.92M20.86M
Employees2,5333,000
SectorHealth CareIndustrials
IndustryIndustrial SpecialtiesIndustrial Specialties

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Materion is about 3.0 times larger than Cadre by market value ($3.81B vs $1.26B).
  • MTRN has outperformed CDRE by 82.2 percentage points over the past year.
  • Cadre offers a meaningfully higher dividend yield (1.34% vs 0.31%).
  • The two companies sit in different sectors: Cadre in Health Care and Materion in Industrials.

About Cadre

CDRE stock →

Cadre Holdings, Inc. manufactures and distributes safety equipment and other related products that provides protection to users in hazardous or life-threatening situations in the United States and internationally.

Health Care · Industrial Specialties · 2,533 employees

About Materion

MTRN stock →

Materion Corporation, together with its subsidiaries, produces advanced engineered materials in the United States, Asia, Europe, and internationally. The company operates in four segments: Performance Materials, Electronic Materials, Precision Optics, and Other.

Industrials · Industrial Specialties · 3,000 employees

CDRE vs MTRN FAQ

Which is bigger, Cadre or Materion?

Materion (MTRN) is larger, with a market capitalization of $3.81B compared with $1.26B for Cadre (CDRE).

Which stock has performed better over the past year, CDRE or MTRN?

MTRN returned +55.33% over the past 12 months, compared with -26.83% for CDRE (price return, excluding dividends). Past performance does not predict future results.

Which has the lower P/E ratio, CDRE or MTRN?

CDRE has the lower trailing P/E at 32.4, versus 37.4 for MTRN. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.

Which pays a higher dividend, Cadre or Materion?

Cadre has the higher yield at 1.34%, compared with 0.31% for Materion.

Are Cadre and Materion in the same industry?

Yes. Both are classified in the Industrial Specialties industry within the Health Care sector.

More comparisons